| CRWV | EPS Watch: Can CoreWeave Keep Riding the AI Spending Wave? | 11/09 18:41 |
| INSP | ROSEN, LEADING INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP | 11/09 18:36 |
| AAAU | Gold ETFs: SPDR Gold Shares Offers Scale While AAAU Is More Affordable | 11/09 18:32 |
| OKLO | Think It's Too Late to Buy This Leading Nuclear Start-Up? Here's Why There's Still Time. | 11/09 18:32 |
| FLR | FLR DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Fluor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLR | 11/09 18:24 |
| WPP | ROSEN, NATIONAL INVESTOR COUNSEL, Encourages WPP plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - WPP | 11/09 18:19 |
| LAW | ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Freeport-McMoRan Inc. Investors to Inquire About Securities Class Action Investigation - FCX | 11/09 18:17 |
| ET | Energy Transfer's Growth Outlook Just Keeps Getting Better | 11/09 18:15 |
| VYM | Vanguard VYM Offers Broader Diversification Than NOBL | 11/09 18:09 |
| BAX | BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit | 11/09 18:08 |
| HDV | Vir Biotechnology Announces AASLD The Liver Meeting® Presentation & New England Journal of Medicine Publication of Phase 2 Data Demonstrating Tobevibart & Elebsiran Combination Deliver High Rates of Undetectable HDV RNA with Favorable Safety Profile | 11/09 18:07 |
| NVDA | Got $5,000? 1 Tech Stock and 1 ETF to Buy and Hold for the Long Term. | 11/09 18:01 |
| META | Meta to Invest $600 Billion to Build AI Data Centers in US | 11/09 17:40 |
| LAW | ROSEN, A LONGSTANDING LAW FIRM, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNPS | 11/09 17:06 |
| POET | Why Poet Technologies Stock Soared 16.2% in October | 11/09 17:05 |
| LDL | Merck's Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with Heterozygous Familial Hypercholesterolemia (HeFH) in Phase 3 CORALreef HeFH Trial | 11/09 17:00 |
| ASA | Ensurge Micropower ASA - Mandatory Notice of Trade for Primary Insiders | 11/09 16:57 |
| NVDA | Why Nvidia Stock Plummeted This Week | 11/09 16:55 |
| ASA | Ensurge Micropower ASA - Key information relating to possible repair issue/subsequent offering | 11/09 16:51 |